Handelsbanken Fonder’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Sell
46,400
-300
-0.6% -$6.63K ﹤0.01% 1019
2026
Q1
$683K Hold
46,700
﹤0.01% 1202
2025
Q4
$590K Sell
46,700
-1,700
-4% -$25.1K ﹤0.01% 1249
2025
Q3
$744K Buy
48,400
+12,100
+33% +$195K ﹤0.01% 1123
2025
Q2
$571K Hold
36,300
﹤0.01% 1192
2025
Q1
$693K Hold
36,300
﹤0.01% 1104
2024
Q4
$865K Buy
36,300
+14,300
+65% +$399K ﹤0.01% 1034
2024
Q3
$616K Hold
22,000
﹤0.01% 1157
2024
Q2
$575K Buy
22,000
+3,000
+16% +$62.4K ﹤0.01% 1093
2024
Q1
$416K Hold
19,000
﹤0.01% 1244
2023
Q4
$442K Hold
19,000
﹤0.01% 1206
2023
Q3
$375K Hold
19,000
﹤0.01% 1201
2023
Q2
$431K Sell
19,000
-6,600
-26% -$133K ﹤0.01% 1152
2023
Q1
$503K Buy
+25,600
New +$491K ﹤0.01% 1005

Other funds holding RXO

Handelsbanken Fonder's RXO Position: Q2 2026 in Review

Handelsbanken Fonder reduced its RXO (RXO) stake by 0.64% in Q2 2026, selling an estimated $6.63K and leaving 46,400 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1019.

Handelsbanken Fonder first reported a position in RXO in Q1 2023 and has held it in 14 quarters since. 89 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Handelsbanken Fonder held 46,400 shares of RXO worth $1.28M as of Q2 2026.
  • Handelsbanken Fonder sold 300 RXO shares in Q2 2026, an estimated $6.63K.
  • RXO made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1019 holding.
  • Handelsbanken Fonder first reported a position in RXO in Q1 2023 and has held it in 14 quarters since.
  • 89 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.